Hip Arthroscopy
Conditions
Brief summary
This study is being conducted to evaluate the effectiveness of post-operative pain control without using narcotic pain medications.
Interventions
DRUGMethocarbamol
500 mg three times a week for 2 weeks postoperatively
DRUGOxycodone
5 mg tablets every 4 hours postoperatively as needed for pain control
DRUGIbuprofen
800 mg three times a day for 2 weeks postoperatively for pain control; not to exceed 3200 mg/day
DRUGGabapentin
300 mg three times a day for 5 days then wean off by day 10 postoperatively
DRUGAcetaminophen
1000 mg three times a day for up to 4 weeks postoperatively for pain control; not to exceed 4 grams per day
Sponsors
Mayo Clinic
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
16 Years to 60 Years
Healthy volunteers
No
Inclusion criteria
• Scheduled for a primary Hip Arthroscopy at Mayo Clinic (Rochester, MN)
Exclusion criteria
* medical history of known allergies or intolerance to allergies or intolerance to Motrin, Gabapentin, Tylenol, dexamethasone, tramadol, or Robaxin. * Substantial alcohol or drug abuse. * History of narcotics within 6 months of surgery. * Pregnancy. * Renal impairment. * Peptic ulcer disease. * GI bleeding.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in pain score | Baseline, 14 days post-operatively | Measure using a visual analog scale (VAS) to rate pain on a scale 0-10; 0=no pain to 10=worst possible pain |
Countries
United States
Outcome results
None listed